Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Ligand Pharmaceuticals Incorporated patent opposition analysis

Get Patent Opposition Report for Ligand Pharmaceuticals Incorporated

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Ligand Pharmaceuticals Incorporated

Explore patent oppositions filed by Ligand Pharmaceuticals Incorporated against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3022231CyclodextrinCURADEV PHARMA PVTJan 18, 2019
EP2786657A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSOct 31, 2018

Top competitors of Ligand Pharmaceuticals Incorporated